Beam Therapeutics BEAM
NASDAQ BEAM
$24.52 +0.29 (+1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Share-based Compensation (2019 - 2026)

Updated

Beam Therapeutics' Share-based Compensation came in at $19.28 million for Q2 2026, down 20.9% from $24.37 million a year earlier but up 1.2% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Share-based Compensation (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Beam Therapeutics reported Share-based Compensation of $81.52 million, down 26.4% year-over-year; for FY2025, it was $94.24 million, down 21.9% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of 43.7% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $120.66 million in FY2024 (+22.3%), $98.65 million in FY2023 (+17.0%), $84.32 million in FY2022 (+93.5%) and $43.57 million in FY2021 (+183.3%).
  • The five-year range for quarterly Share-based Compensation is $12.97 million (Q3 2021) to $31.6 million (Q2 2024).
  • Year-over-year, Share-based Compensation has declined for six consecutive quarters, with an average decline of 11.1% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q3 2021 (growth of 330.5%), and the weakest in Q4 2025 (a decline of 32.3%).
  • Business Quant data shows BEAM's Share-based Compensation at $19.04 million (Q1 2026), $20.45 million (Q4 2025) and $22.75 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Beam Therapeutics 2.50 Bn 2.50 Bn - 19.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.28 Mn
Mar 31, 2026 19.04 Mn
Dec 31, 2025 20.45 Mn
Sep 30, 2025 22.75 Mn
Jun 30, 2025 24.37 Mn
Mar 31, 2025 26.68 Mn
Dec 31, 2024 30.22 Mn
Sep 30, 2024 29.56 Mn
Jun 30, 2024 31.60 Mn
Mar 31, 2024 29.28 Mn
Dec 31, 2023 22.62 Mn
Sep 30, 2023 25.84 Mn
Jun 30, 2023 26.28 Mn
Mar 31, 2023 23.92 Mn
Dec 31, 2022 22.50 Mn
Sep 30, 2022 22.21 Mn
Jun 30, 2022 21.58 Mn
Mar 31, 2022 18.04 Mn
Dec 31, 2021 15.50 Mn
Sep 30, 2021 12.97 Mn
API Access

Beam Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BEAM&period=max&api_key=YOUR_API_KEY